Medicare Enrolled

Dr. Alicia Della Volpe, MD

Pediatric Hematology-Oncology · Miami, FL
Low-engagement
3200 SW 60TH CT STE 203, Miami, FL 33155
3056666511
In practice since 2010 (15 years)
NPI: 1972829828 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Della Volpe from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Della Volpe? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Della Volpe

Dr. Alicia Della Volpe is a pediatric hematology-oncology in Miami, FL, with 15 years in practice.

Between the years covered by Open Payments, Dr. Della Volpe received a total of $2,727 from 27 pharmaceutical and/or device companies across 88 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pediatric hematology-oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Della Volpe is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice$ $2,727 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$2,727
Total received (2018-2024)
Avg $390/year across 7 years
Top 29% in FL for pediatric hematology-oncology
27
Companies
88
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,727 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$176
2023
$185
2022
$446
2021
$354
2020
$314
2019
$434
2018
$820

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Sobi, Inc
$376
Gilead Sciences, Inc.
$354
AstraZeneca Pharmaceuticals LP
$319
AbbVie Inc.
$252
AbbVie, Inc.
$246
Baxter Healthcare
$159
Genentech USA, Inc.
$125
VERTEX PHARMACEUTICALS INCORPORATED
$107
Philips Electronics North America Corporation
$105
CSL Behring
$92
SOBI, INC
$86
Advanced Respiratory, Inc
$79
ABBVIE INC.
$47
GENZYME CORPORATION
$44
AIMMUNE THERAPEUTICS, INC.
$40
NESTLE HEALTHCARE NUTRITION INC.
$37
Fisher & Paykel Healthcare Inc
$36
Nestle HealthCare Nutrition Inc.
$35
Zogenix Inc.
$24
Alcresta Therapeutics, Inc.
$24
Biogen, Inc.
$22
GlaxoSmithKline, LLC.
$22
VIVUS LLC
$21
Tactile Systems Technology Inc
$21
Novartis Pharmaceuticals Corporation
$20
ADVANCED RESPIRATORY, INC
$18
Breas Medical, Inc.
$17
Top 3 companies account for 38.5% of total payments
Associated products mentioned in payments ›
(8874) inCourage · Afstyla · CREON · Cayston · Creon · DUPIXENT · FASENRA · FISHER & PAYKEL HEALTHCARE · Fintepla · Flexitouch Plus · Hillrom - Synclara Cough System · Hillrom - Vest System Model 105 Home Care · Hillrom - Volara System · Idelvion · NUCALA · QSYMIA · RELIZORB · SPINRAZA · SYNAGIS · Synagis · TOBI PODHALER · TRIKAFTA · The Vest System Model 105 Home Care · The VisiVest Airway Clearance System · Vivo 45 LS · ZENPEP · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pediatric hematology-oncology in Miami?
Compare pediatric hematology-oncologys in the Miami area by procedure volume, costs, and industry payment transparency.
Browse pediatric hematology-oncologys nearby

Geographic Context

Pediatric Hematology-Oncologys within 10 mi
16
Per 100K population
0.6
County median income
$68,694
Nearest hospital
KERALTY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Della Volpe is a pediatric hematology-oncology, and low-engagement industry engagement, with 15 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Della Volpe receive payments from pharmaceutical companies?
Yes. Dr. Della Volpe received a total of $2,727 from 27 companies across 88 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Della Volpe) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →